This compound is a brominated quinolinone derivative used as a pharmaceutical intermediate. It features an amide group, an aromatic ring, an ether linkage, and a halogen substituent, with moderate lipophilicity and a polar surface area of 38.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 129722-34-5
7,7'-[Butane-1,4-diylbis(oxy)]di(3,4-dihydroquinolin-2(1H)-one)
pharmaceutical raw material
3,4-Dihydro-7-(4-chlorobutoxy)-2(1H)-quinolinone
pharmaceutical raw material
2-chloro-4-(1H-pyrazol-5-yl)benzonitrile
pharmaceutical intermediate
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile
pharmaceutical intermediate
3-acetyl-1H-pyrazole-5-carboxylic acid
pharmaceutical intermediate
Di-tert-butyl (2-oxopropane-1,3-diyl)dicarbamate
pharmaceutical intermediate
7-Methoxy-3,4-dihydroquinolin-2(1H)-one
pharmaceutical intermediate
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
pharmaceutical intermediate
7-(4-bromobutoxy)-3,4-dihydro-1H-quinolin-2-one
URHLNHVYMNBPEO-UHFFFAOYSA-N
C1CC(=O)NC2=C1C=CC(=C2)OCCCCBr